EP2796134
Combination of the peptide epoxyketone proteasome inhibitor carfilzomib with melphalan for use in the treatment of multiple myeloma
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.10.2009EP published:
7.12.2016EP application number:
14171395.8
EPO information:
European Patent Register
Max expiry date:
20.10.2029
Title:
Combination of the peptide epoxyketone proteasome inhibitor carfilzomib with melphalan for use in the treatment of multiple myeloma
Timeline
Today
21.10.2009EP application
7.12.2016EP Publication
Owner
Name:
Onyx Therapeutics, Inc.Address:
One Amgen Center Drive, 91320, Thousand Oaks, CA, US
Inventor
Name:
Kirk, Christopher J.Address:
San Francisco, CA California, US
Name:
Demo, Susan D.Address:
San Francisco, CA California, US
Name:
Bennett, Mark K.Address:
Moraga, CA California, US
Priority
Number:
196945 PDate:
21.10.2008Country:
US
Classification
Categories:
A61K 31/167, A61K 38/08, A61K 31/165, A61K 38/04, A61P 35/00, A61K 38/55, A61K 45/06, A61K 38/06, A61K 31/198